MERGER ANNOUNCED!!!
Stocknight ListServer
bounce-stocknight-163101 at lyris.stocknight.com
Wed Jun 13 15:23:21 PDT 2001
[Stocknight.com] [Image]
[Image]
Issue 7 June 13, 2001
Editor's Note [Image]
Generally, at StockNight we tend to feature financial news items
that have come out after market but sometimes news falls into our
hands that is of such significance that we distribute to our
members as soon as possible. We just received authorization
moments ago to send this news to our members. Read on!
Elast Technologies Inc. [Image]
Elast Technologies Inc. (OTCBB: ELTI) is presently engaged in two
unique industries using applications of its patented technology.
The first, the innovative Electronic Allergo Sensitivity Test, is
an instrument with which allergies and food and chemical
sensitivities may be detected without invading the body. Another
application, the Bio-Potential Instrument, allows chiropractors
the means with which to gauge the benefit of chiropractic care.
The merger with PTS Inc. today brings yet another unique body of
technology under the ELTI listing, some of whch could be affected
dramatically by Chinese admission to the World Trade
Organization. Click here to read CNN's take on China, Technology
& the WTO.
Merger News [Image]
ELAST Technologies Merges with PTS, Inc.
LAS VEGAS-- ELAST Technologies, Inc. ( OTCBB: ELTI ) announced it
has merged with PTS, Inc., a Nevada corporation organized in 1999.
PTS is committed to the development of a truly global trading
platform to facilitate everyday business transactions. Through its
pending joint venture with a major Shanghai information technology
firm and the venture's forthcoming launch of a China based
business-to-business platform PTS will take a major step towards
this goal. PTS' China platform will permit real time business
transactions such as electronic payments, contract fulfillment and
the dissemination of financial information in China. Upon China's
accession to the World Trade Organization PTS will be uniquely
positioned to expand its platform globally conducting transactions
of any size, anywhere, across multiple currencies.
Through this merger ELAST Technologies will be favorably
positioned in two important and emerging fields, electronic
payment and electronic medicine, and the potential presented by
each is limitless. Moreover, ``ELAST's merger with PTS should
assure early perfection and delivery of ELAST's diagnostic tools,
as well as reduced engineering and production costs,'' predicts
Thomas F. Krucker, President and CEO.
Currently, ELAST is engaged in the development of two separate
diagnostic tools: its allergy testing device and its chiropractic
outcome-measuring instrument. These instruments stem from the
Company's identification of commercial applications for worldwide
patents secured by its founder, Robert D. Milne, MD. A primary
application is the innovative Electronic Allergo Sensitivity Test
or the ELAST Device(TM). The ELAST Device(TM) is a non-invasive
medical tool that is being designed to accurately diagnose
allergies, as well as food and chemical sensitivities. ELAST
Technologies holds the patents, trademarks and legal rights to
manufacture, sell and lease its electronic allergy-testing device
and is making great strides in refining the prototype.
A second application of ELAST's technologies is ELAST's
Bio-Potential Instrument. The Bio-Potential Instrument can provide
doctors of chiropractic with the means to measure the damage of
vertebral subluxations, as well as the normalizing effect of
chiropractic adjustments. ELAST plans initial delivery of its
Bio-Potential Instrument shortly.
Again, this is just part of the release. Click here to read it in
its entirety: ELTI NEWS
Related links, Due Diligence & Financials:
Elast Technologies Corporate Home Page
More ELTI Financial Data
ELTI NEWS
New Feature! Question of the Day: Will the Palestinian/Israeli
cease fire last? Who should occupy the disputed land? Click here
to comment.
Disclaimer & Safe Harbor Statement:
SafeHarbor:
This fact sheet contains forward-looking statements within the
meaning of Private Securities Litigation Reform Act of 1995,
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of the 1934. These forward-looking
statements can be identified by the use of forward-looking
terminology such as may, could, expected to and believes.
Actual events or performance involve risks and uncertainties that
could differ materially from those anticipated in such
forward-looking statements. Factors that could cause actual
results to differ materially from those projected in
forward-looking statements include competition, themanagement of
our growth and the ability to deliver new products to market on
time. Such forward-looking statements are subject to other risks
and uncertainties, which are detailed in the Companys filings
with the Securities and Exchange Commission.
Disclaimer:
StockNight.com is being published by Integrity Media Inc. (IMI), a
public relations firm. The information, opinions and analysis
contained herein are based on sources believed to be reliable but
no representation, expressed or implied, is made as to its
accuracy, completeness or correctness. This report is for
information purposes only and should not be used as the basis for
any investment decision. IMI and/or its affilitiates and
subcontractors have been compensated 321,875 restricted and free
trading shares, for the preparation and dissemination of this
report and previous public relations efforts. This compensation
constitutes a conflict of interest as to IMIs ability to remain
objective in its communication regarding the subject company.
Write IMI for detailed disclosure as required by Rule 17b of the
Securities Act of 1933/1934. IMI is not an investment advisor and
this report is not investment advice. This information is neither
a solicitation to buy nor an offer to sell securities. Information
contained herein contains forward-looking statements and is
subject to significant risks and uncertainties, which will affect
the results. The opinions contained herein reflect our current
judgment and are subject to change without notice. IMI and/or its
affiliates, associates and employees from time to time may have
either a long or short position in securities mentioned.
Information contained herein may not be reproduced in whole or in
part without the express written consent of Integrity Media
Incorporated.
---
You are currently subscribed to stocknight as: cypherpunks at algebra.com
To unsubscribe send a blank email to leave-stocknight-163101P at lyris.stocknight.com
-------------- next part --------------
A non-text attachment was scrubbed...
Name: not available
Type: text/html
Size: 10900 bytes
Desc: not available
URL: <https://lists.cpunks.org/pipermail/cypherpunks-legacy/attachments/20010613/432977bc/attachment.txt>
More information about the cypherpunks-legacy
mailing list